Insights On Pharmaceutical Packaging

  1. FAQs On The Revised EU GMP Annex 1: Volume 1 3/5/2025

    The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.

  2. Clinical, Commercial Packaging: Delivering Next-Gen Therapies 4/7/2026

    See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

  3. Stability Issues Unique To Liquid Injectables And How To Avoid Them 3/23/2026

    Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.

  4. Understanding Modern Storage Tank Design And Fabrication 7/28/2025

    Industries rely on advanced storage tanks and pressure vessels to safely manage liquids, gases, and powders. Discover how custom-engineered solutions can enhance efficiency, safety, and compliance.

  5. Why A Leading Manufacturing Partner Chose NeoTOP Packaging Machines 8/2/2024

    Learn how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.

  6. Rare Diseases And The Integrated CDMO Support System 4/7/2026

    Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.

  7. What To Look For In A Pharma Contract Packaging Partner 2/27/2026

    Teams face rising pressure around compliance, complexity, and speed. These five essential qualities help identify packaging partners who can support production, reduce risk, and align with your needs.

  8. Key Considerations When Choosing A Device For Dry Powder Nasal Delivery 10/21/2024

    Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.

  9. 5 Critical PUPSIT Considerations For Sponsors Targeting The EU Market 1/22/2026

    To ensure compliance with EU GMP Annex 1 guidelines and drug product approval, familiarize yourself with PUPSIT: how it works, why it’s needed, and strategies to maximize success.

  10. How DFM Promotes Scalability, Repeatability, And Profitability 6/28/2024

    Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production.